These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30189291)

  • 21. Genetics and personalized medicine in antidepressant treatment.
    Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
    Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in genes related to the hypothalamic-pituitary-adrenal axis and antidepressant response - Systematic review.
    Fischer S; Gardini ES; Haas F; Cleare AJ
    Neurosci Biobehav Rev; 2019 Jan; 96():182-196. PubMed ID: 30465786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
    J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of the glucocorticoid receptor gene and major depression.
    van Rossum EF; Binder EB; Majer M; Koper JW; Ising M; Modell S; Salyakina D; Lamberts SW; Holsboer F
    Biol Psychiatry; 2006 Apr; 59(8):681-8. PubMed ID: 16580345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying genetic loci associated with antidepressant drug response with drug-gene interaction models in a population-based study.
    Noordam R; Direk N; Sitlani CM; Aarts N; Tiemeier H; Hofman A; Uitterlinden AG; Psaty BM; Stricker BH; Visser LE
    J Psychiatr Res; 2015 Mar; 62():31-7. PubMed ID: 25649181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noncoding RNAs in Depression.
    Lin R; Turecki G
    Adv Exp Med Biol; 2017; 978():197-210. PubMed ID: 28523548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circadian rhythms and treatment implications in depression.
    Monteleone P; Martiadis V; Maj M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1569-74. PubMed ID: 20691746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
    Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of proopiomelanocortin polymorphisms with the risk of major depressive disorder and the response to antidepressants via interactions with stressful life events.
    Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
    J Neural Transm (Vienna); 2015 Jan; 122(1):59-68. PubMed ID: 25448875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genetic variant in 12q13, a possible risk factor for bipolar disorder, is associated with depressive state, accounting for stressful life events.
    Shimasaki A; Kondo K; Saito T; Esaki K; Otsuka Y; Mano K; Ikeda M; Iwata N
    PLoS One; 2014; 9(12):e115135. PubMed ID: 25517604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression.
    Serafini G; Pompili M; Innamorati M; Dwivedi Y; Brahmachari G; Girardi P
    Curr Pharm Des; 2013; 19(10):1898-922. PubMed ID: 23173582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The possible role of maternal bonding style and CHRNB2 gene polymorphisms in nicotine dependence and related depressive phenotype.
    Csala I; Egervari L; Dome P; Faludi G; Dome B; Lazary J
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():84-90. PubMed ID: 25640319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
    Bousman CA; Arandjelovic K; Mancuso SG; Eyre HA; Dunlop BW
    Pharmacogenomics; 2019 Jan; 20(1):37-47. PubMed ID: 30520364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics.
    Shalimova A; Babasieva V; Chubarev VN; Tarasov VV; Schiöth HB; Mwinyi J
    Pharmacogenomics; 2021 Jun; 22(8):485-503. PubMed ID: 34018822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omega 3 polyunsaturated fatty acids and the treatment of depression.
    Deacon G; Kettle C; Hayes D; Dennis C; Tucci J
    Crit Rev Food Sci Nutr; 2017 Jan; 57(1):212-223. PubMed ID: 25830700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic studies: a tool to improve antidepressant therapy.
    Ramos M; Berrogain C; Concha J; Lomba L; García CB; Ribate MP
    Drug Metab Pers Ther; 2016 Dec; 31(4):197-204. PubMed ID: 27889704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.